Erik Kinnman, M.D, Ph.D, 49, will join Biovitrum as Vice President Investor Relations & Public Affairs. Erik will also assume the accountability of Chief Strategic Officer, managing the continuation of Biovitrum’s business strategy. He is leaving his current position as Project Director Global R&D Strategy at AstraZeneca.
